Cholera vaccine: WHO position paper, August 2017-Recommendations

Cholera vaccine: WHO position paper, August 2017-Recommendations
复制标题

DOI:
10.1016/j.vaccine.2017.09.034
复制
发表时间:
2018-06-07
期刊:
影响因子:
5.5
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

被引文献

相似文献

本文介绍了世界卫生组织(WHO)关于霍乱疫苗使用的建议,摘自霍乱疫苗:WHO立场文件,2017年8月,发表在每周流行病学记录(霍乱疫苗,2017)1。该立场文件取代了2010年世卫组织关于霍乱疫苗的立场文件(霍乱疫苗,2010)[2]。它结合了最新的证据,霍乱疫苗接种,并提供了修订建议的目标人群霍乱immunization.Footnotes,本文提供了一些核心参考,包括参考分级表,评估科学证据的质量,和证据的建议表。根据其就卫生政策事项向会员国提供指导的任务规定,世卫组织发布了一系列定期更新的关于预防具有国际公共卫生影响的疾病的疫苗和疫苗组合的立场文件。这些论文主要关注大规模免疫规划中疫苗的使用;它们总结了有关疾病和疫苗的基本背景信息,并总结了世卫组织目前在全球范围内使用疫苗的立场。2017年4月,战略咨询专家组(SAGE)讨论了关于使用霍乱疫苗的建议;在这些会议上提出的证据可以在www.who.int/immunization/sage/meetings/2017/Aprilipresentations_background_docs/en/上获得。(C)2017世界卫生组织。由爱思唯尔有限公司出版。保留所有权利。
The article presents the World Health Organization's (WHO) recommendations on the use of cholera vaccines excerpted from the Cholera vaccines: WHO position paper, August 2017, published in the Weekly Epidemiological Record (Cholera vaccine, 2017) 1]. This position paper replaces the 2010 WHO position paper on cholera vaccines (Cholera vaccine, 2010) [2]. It incorporates the most recent evidence on cholera vaccination and provides revised recommendations on the target populations for cholera immunization.Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of cholera vaccines were discussed by the Strategic Advisory Group of Experts (SAGE) in April 2017; evidence presented at these meetings can be accessed at: www.who.int/immunization/sage/meetings/2017/Aprilipresentations_background_docs/en/. (C) 2017 World Health Organization. Published by Elsevier Ltd. All rights reserved.